Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands |
3 Months Ended |
Apr. 29, 2017 |
Apr. 30, 2016 |
| Net cash provided by operating activities |
|
|
| Net earnings |
$ 14,884
|
$ 17,878
|
| Adjustments to reconcile net earnings to net cash provided by operating activities: |
|
|
| Depreciation |
11,156
|
9,019
|
| Amortization of capitalized software |
3,560
|
3,161
|
| Amortization of intangible assets |
1,033
|
920
|
| Amortization of debt issuance costs and debt discount |
432
|
432
|
| Share-based compensation expense |
2,711
|
1,987
|
| Excess tax benefit related to share-based plans |
0
|
(3,163)
|
| Loss on disposal of property and equipment |
130
|
79
|
| Impairment charges for property and equipment |
949
|
465
|
| Deferred rent |
(243)
|
222
|
| Provision for doubtful accounts |
91
|
182
|
| Changes in operating assets and liabilities: |
|
|
| Receivables |
46,002
|
36,522
|
| Inventories |
20,515
|
60,532
|
| Prepaid expenses and other current and noncurrent assets |
11,014
|
16,438
|
| Trade accounts payable |
(41,142)
|
(48,648)
|
| Accrued expenses and other liabilities |
(5,836)
|
(31,631)
|
| Other, net |
128
|
765
|
| Net cash provided by operating activities |
65,384
|
65,160
|
| Investing Activities |
|
|
| Purchases of property and equipment |
(10,978)
|
(16,367)
|
| Capitalized software |
(1,390)
|
(1,820)
|
| Net cash used for investing activities |
(12,368)
|
(18,187)
|
| Financing Activities |
|
|
| Borrowings under revolving credit agreement |
195,000
|
103,000
|
| Repayments under revolving credit agreement |
(220,000)
|
(103,000)
|
| Dividends paid |
(3,025)
|
(3,068)
|
| Acquisition of treasury stock |
(5,993)
|
(12,130)
|
| Issuance of common stock under share-based plans, net |
(2,422)
|
(4,149)
|
| Excess tax benefit related to share-based plans |
0
|
3,163
|
| Net cash used for financing activities |
(36,440)
|
(16,184)
|
| Effect of exchange rate changes on cash and cash equivalents |
(92)
|
594
|
| Increase in cash and cash equivalents |
16,484
|
31,383
|
| Cash and cash equivalents at beginning of period |
55,332
|
118,151
|
| Cash and cash equivalents at end of period |
$ 71,816
|
$ 149,534
|